GlassScriptPhysician profile
Tyler Thorne
NPI 1568967230
$2,344.65
in general payments reported to CMS, 2019-2025
19 companies · $2,006 in 2025
The $2,006 reported for 2025 was more than what 89% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $24.90 · 2024: $314 · 2025: $2,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,344.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calliditas Therapeutics US INC. | $293.11 | 2025 | Tarpeyo |
| Travere Therapeutics, INC. | $240.54 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $238.14 | 2024-2025 | Terlivaz, Acthar |
| Astrazeneca Pharmaceuticals LP | $219.41 | 2024-2025 | Lokelma, Farxiga |
| Amgen INC. | $210.59 | 2025 | Krystexxa, Tavneos, Uplizna |
| Novartis Pharmaceuticals Corporation | $206.59 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $175.34 | 2025 | Jynarque, Voyxact |
| Vantive US Healthcare LLC | $115.87 | 2025 | Renal - Acute |
| Novo Nordisk INC | $108.38 | 2024-2025 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.17 | 2025 | Jardiance |
| Apellis Pharmaceuticals, INC. | $90.06 | 2025 | Empaveli |
| Akebia Therapeutics INC | $79.68 | 2025 | Vafseo |
| Scpharmaceuticals INC. | $67.05 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.86 | 2024-2025 | |
| Aurinia Pharma U.S., INC. | $51.42 | 2023-2025 | Lupkynis |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $26.97 | 2025 | Veltassa |
| Renalytix Ai, INC. | $22.48 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Opko Pharmaceuticals, LLC | $21.45 | 2024 | Rayaldee |
| Ardelyx, INC. | $13.54 | 2025 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Thorne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.